ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE and DRUG INEFFECTIVE FOR UNAPPROVED INDICATION

Overview

DRUG INEFFECTIVE FOR UNAPPROVED INDICATION is the #14 most commonly reported adverse reaction for ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE, manufactured by Bayer HealthCare LLC.. There are 3 FDA adverse event reports linking ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE to DRUG INEFFECTIVE FOR UNAPPROVED INDICATION. This represents approximately 1.7% of all 179 adverse event reports for this drug.

Patients taking ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE who experience drug ineffective for unapproved indication should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

DRUG INEFFECTIVE FOR UNAPPROVED INDICATION is a less commonly reported adverse event for ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE, but still significant enough to appear in the safety profile.

Other Side Effects of ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE

In addition to drug ineffective for unapproved indication, the following adverse reactions have been reported for ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE:

• CEREBROVASCULAR ACCIDENT — 9 reports
• DRUG INEFFECTIVE — 7 reports
• DRUG DEPENDENCE — 5 reports
• MALAISE — 5 reports
• PRODUCT USE ISSUE — 5 reports
• CHOKING — 4 reports
• DIZZINESS — 4 reports
• NAUSEA — 4 reports
• PRODUCT USE IN UNAPPROVED INDICATION — 4 reports
• RECTAL HAEMORRHAGE — 4 reports

Other Drugs Associated with DRUG INEFFECTIVE FOR UNAPPROVED INDICATION

The following drugs have also been linked to drug ineffective for unapproved indication in FDA adverse event reports:

Does ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE cause DRUG INEFFECTIVE FOR UNAPPROVED INDICATION?

DRUG INEFFECTIVE FOR UNAPPROVED INDICATION has been reported as an adverse event in 3 FDA reports for ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is DRUG INEFFECTIVE FOR UNAPPROVED INDICATION with ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE?

DRUG INEFFECTIVE FOR UNAPPROVED INDICATION accounts for approximately 1.7% of all adverse event reports for ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE, making it a notable side effect.

What should I do if I experience DRUG INEFFECTIVE FOR UNAPPROVED INDICATION while taking ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE?

If you experience drug ineffective for unapproved indication while taking ASPIRIN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE BITARTRATE, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Related Pages